Effects of a nurse-managed program on hepatitis A and B vaccine completion among homeless adults

Nursing Research

Volumn 58, Issue 1, 2009, Pages 13-22

  Nyamathi, Adeline ^a,e   Liu, Yihang ^a   Marfisee, Mary ^b   Shoptaw, Steven ^c   Gregerson, Paul ^d   Saab, Sammy ^c   Leake, Barbara ^c   Tyler, Darlene ^a   Gelberg, Lillian ^c  

^a School of Nursing

^b Drew UCLA

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Weingart Center   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

HAV HBV vaccine completion homeless adults nurse case managed program substance abuse

Indexed keywords

HEPATITIS A HEPATITIS B VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; VACCINE;

ADULT; ARTICLE; CASE MANAGEMENT; CLINICAL TRIAL; CONTACT EXAMINATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EDUCATION; FEMALE; HEALTH CARE QUALITY; HEPATITIS A; HEPATITIS B; HIGH RISK BEHAVIOR; HOMELESSNESS; HUMAN; MALE; MIDDLE AGED; MOTIVATION; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NURSE ATTITUDE; NURSING; NURSING EVALUATION RESEARCH; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SOCIOECONOMICS; STATISTICAL MODEL; STATISTICS; UNITED STATES; VACCINATION;

ADULT; CASE MANAGEMENT; CONTACT TRACING; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HEPATITIS B; HEPATITIS B VACCINES; HOMELESS PERSONS; HUMANS; LOGISTIC MODELS; LOS ANGELES; MALE; MIDDLE AGED; MOTIVATION; MULTIVARIATE ANALYSIS; NURSE'S ROLE; NURSING EVALUATION RESEARCH; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PROGRAM EVALUATION; PROSPECTIVE STUDIES; RISK-TAKING; SINGLE-BLIND METHOD; SOCIOECONOMIC FACTORS; VACCINATION; VACCINES, COMBINED;

EID: 58149399354     PISSN: 00296562     EISSN: None     Source Type: Journal    
DOI: 10.1097/NNR.0b013e3181902b93     Document Type: Article

References (40)

1. Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and the acceptance of and adherence to antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28(1), 47-58.
2. Anglin, M. D., Danila, B., Tyan, T., & Mantius, K. (1996). Staying in touch: A fieldwork manual of tracking procedures for locating substance abusers for follow-up studies. Washington, DC: National Evaluation Data and Technical Assistance Center.
3. Centers for Disease Control & Prevention. (2001). Hepatitis B vaccination for injection drug users-Pierce County, Washington, 2000. Morbidity and Mortality Weekly Report, 50, 388-390, 399.
4. Centers for Disease Control & Prevention. (2006). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States. Morbidity and Mortality Weekly Report, 55(RR-16), 1-25.
5. Centers for Disease Control & Prevention. (2008). Surveillance for acute viral hepatitis-United States, 2006. Morbidity and Mortality Weekly Report, 57(SS02), 1-24.
6. Cohen, C. A., London, W. T., Evans, A. A., Block, J., Conti, M. C., & Block, T. (2007). Underestimation of chronic hepatitis B in APIs: A call for advocacy and action [Abstract 149577]. Paper presented at the 135th American Public Health Association Annual Meeting & Exposition.
7. Desai, R. A., Rosenheck, R. A., & Agnello, V. (2003). Prevalence of hepatitis C virus infection in a sample of homeless veterans. Social Psychiatry and Psychiatric Epidemiology, 38(7), 396-401.
8. Frangakis, C. E., Brookmeyer, R. S., Varadhan, R., Mahboobeh, S., Vlahov, D., & Strathdee, S. A. (2004). Methodology for evaluating a partially controlled longitudinal treatment using principal stratification, with application to a needle exchange program. Journal of the American Statistical Association, 99(465), 239-249.
9. Garfein, R. S., Vlahov, D., Galai, N., Doherty, M. C, & Nelson, K. E. (1996). Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. American Journal of Public Health, 86(5), 655-661.
10. Gelberg, L., Robertson, M. J., Leake, B., Wenzel, S. L., Bakhtiar, L, Hardie, E. A., et al. (2001). Hepatitis B among homeless and other impoverished US military veterans in residential care in Los Angeles. Public Health, 115(4), 286-291.
11. Goldstein, S. T., Alter, M. J., Williams, I. T., Moyer, L. A., Judson, F. N., Mottram, K., et al. (2002). Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: Implications for vaccination programs. Journal of Infectious Diseases, 185(6), 713-719.
12. Greengold, B., Nyamathi, A., Kominski, G., Hodge, F., Singer, M., & Spiegel, B. (under review). Cost effectiveness analysis of behavioral intervention to improve vaccination compliance in homeless adults. Vaccine.
13. Keystone, J. S., & Hershey, J. H. (2008). The underestimated risk of hepatitis A and hepatitis B: Benefits of an accelerated vaccination schedule. International Journal of Infectious Diseases, 22(1), 3-11.
14. Lamagni, T. L., Hope, V. D., Davison, K. L., Parry, J. V., & Gill, O. N. (2001). Failure to vaccinate current injecting drug users against hepatitis B in England and Wales. Communicable Disease and Public Health, 4(1), 71-72.
15. Lazarus, R., & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.
16. Liu, Z., & Hou, J. (2006). Hepatitis B virus (HBV) and hepatitis C virus (HCV) dual infection. International Journal of Medical Sciences, 3(2), 57-62.
17. Lum, P. J., Ochoa, K. C, Hahn, J. A., Shafer, K. P., Evans, J. L., & Moss, A. R. (2003). Hepatitis B virus immunization among young injection drug users in San Francisco, Calif: The UFO study. American Journal of Public Health, 93(6), 919-923.
18. Morisky, D. E., Malotte, C. K., Ebin, V., Davidson, P., Cabrera, D., Trout, P. T., et al. (2001). Behavioral interventions for the control of tuberculosis among adolescents. Public Health Reports, 116(6), 568-574.
19. Moss, A. R., Hahn, J. A., Perry, S., Charlebois, E. D., Guzman, D., Clark, R. A., et al. (2004). Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: A prospective study. Clinical Infectious Diseases, 39(8), 1190-1198.
20. Nyamathi, A. (1989). Comprehensive health seeking and coping paradigm. Journal of Advanced Nursing, 14(4), 281-290.
21. Nyamathi, A., Berg, J., Jones, T., & Leake, B. (2005). Predictors of perceived health status of tuberculosis-infected homeless. Western Journal of Nursing Research, 27(7), 896-910.
22. Nyamathi, A. M., Christiani, A., Nahid, P., Gregerson, P., & Leake, B. (2006). A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. International Journal of Tuberculosis and Lung Disease, 10(7), 775-782.
23. Nyamathi, A. M., Dixon, E. L., Robbins, W., Smith, C., Wiley, D., Leake, B., et al. (2002). Risk factors for hepatitis C virus infection among homeless adults. Journal of General Internal Medicine, 17(2), 134-143.
24. Nyamathi, A., Dixon, E. L., Shoptaw, S., Marfisee, M., Gelberg, L., Williams, S., et al. (2007). Profile of lifetime methamphetamine use among homeless adults in Los Angeles. Drug and Alcohol Dependence, 92(1-3), 277-281.
25. Nyamathi, A., Nahid, P., Berg, J., Burrage, J., Christiani, A., Aqtash, S., et al. (2008). Efficacy of nurse case-managed intervention for latent tuberculosis among homeless subsamples. Nursing Research, 57(1), 33-39.
26. Nyamathi, A. M., Stein, J. A., Dixon, E., Longshore, D., & Galaif, E. (2003). Predicting positive attitudes about quitting drug and alcohol use among homeless women. Psychology of Addictive Behaviors, 17(1), 32-41.
27. Ompad, D. C., Galea, S., Wu, Y., Fuller, C. M., Latka, M., Koblin, B., et al. (2004). Acceptance and completion of hepatitis B vaccination among drug users in New York City. Communicable Disease and Public Health, 7(4), 294-300.
28. Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385-401.
29. Rich, J. D., Ching, C. G., Lally, M. A., Gaitanis, M. M., Schwartzapfel, B., Charuvastra, A., et al. (2003). A review of the case for hepatitis B vaccination of high-risk adults. American Journal of Medicine, 114(4), 316-318.
30. Rubenstein, L. V., Calkins, D. R., Young, R. T., Cleary, P. D., Fink, A., Kosecoff, J., et al. (1989). Improving patient function: A randomized trial of functional disability screening. Annals of Internal Medicine, 111(10), 836-842.
31. Santibanez, S. S., Garfein, R. S., Swartzendruber, A., Kerndt, P. R., Morse, E., Ompad, D., et al. (2005). Prevalence and correlates of crack-cocaine injection among young injection drug users in the United States, 1997-1999. Drug and Alcohol Dependence, 77(3), 227-233.
32. Schlotfeldt, R. M. (1981). Nursing in the future. Nursing Outlook, 29(5), 295-301.
33. Seal, K. H., Ochoa, K. C., Hahn, J. A., Tulsky, J. P., Edlin, B. R., & Moss, A. R. (2000). Risk of hepatitis B infection among young injection drug users in San Francisco: Opportunities for intervention. Western Journal of Medicine, 172(1), 16-20.
34. Sherbourne, C. D., & Stewart, A. L. (1991). The MOS social support survey. Social Science & Medicine, 32(6), 705-714.
35. Simpson, D., & Chatham, L. (1995). TCU/DATAR forms manual. Ft. Worth, TX: Institute of Behavioral Research, Texas Christian University.
36. Sorensen, J. L., Masson, C. L., & Perlman, D. C. (2002). HIV/Hepatitis prevention in drug abuse treatment programs: Guidance from research. NIDA Science & Practice Perspectives, 1(1), 4-11.
37. Stewart, A. L, Hays, R. D, & Ware, J. E., Jr. (1988). The MOS short-form general health survey. Reliability and validity in a patient population. Medical Care, 26(7), 724-735.
38. Trubatch, B. N., Fisher, D., Cagel, H. H., & Fenaughty, A. M. (2000). Vaccination strategies for targeted and difficult-toaccess groups. American Journal of Public Health, 90(3), 447.
39. Tulsky, J. P., Hahn, J. A, Long, H. L., Chambers, D. B., Robertson, M. J., Chesney, M. A., et al. (2004). Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. International Journal of Tuberculosis and Lung Disease, 8(1), 83-91.
40. Wasley, A., Miller, J. T., & Finelli, L. (2007). Surveillance for acute viral hepatitis-United States, 2005. Morbidity and Mortality Weekly Report. CDC Surveillance Summaries, 56(3), 1-24.